203 related articles for article (PubMed ID: 11571737)
1. Variant expression of CD44 in preneoplastic lesions of the lung.
Wimmel A; Kogan E; Ramaswamy A; Schuermann M
Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
[TBL] [Abstract][Full Text] [Related]
3. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis?
Fasano M; Sabatini MT; Wieczorek R; Sidhu G; Goswami S; Jagirdar J
Cancer; 1997 Jul; 80(1):34-41. PubMed ID: 9210706
[TBL] [Abstract][Full Text] [Related]
4. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
5. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732
[TBL] [Abstract][Full Text] [Related]
14. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
Jiang H; Zhao W; Shao W
Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197.
Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V
Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086
[TBL] [Abstract][Full Text] [Related]
18. CD44s and CD44v6 expression in head and neck epithelia.
Mack B; Gires O
PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
[TBL] [Abstract][Full Text] [Related]
19. Temporal variation in the distribution of hyaluronic acid, CD44s, and CD44v6 in the human endometrium across the menstrual cycle.
Afify AM; Craig S; Paulino AF
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):328-33. PubMed ID: 16932025
[TBL] [Abstract][Full Text] [Related]
20. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues.
Bahar R; Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Dec; 26(6):443-6. PubMed ID: 9418147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]